Mangiferin ameliorates fatty liver via modulation of autophagy and inflammation in high-fat-diet induced mice.
Wang, Hu; Zhu, Yang-Yang; Wang, Li; Teng, Tian; Zhou, Meng; Wang, Shu-Guang; Tian, Yi-Zhu; Du, Lei; Yin, Xiao-Xing; Sun, Ying.
; 96: 328-335, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29024899
Pilose antler peptide attenuates high-fat-diet-induced liver injury.
Akebia Saponin D Decreases Hepatic Steatosis through Autophagy Modulation.
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
NASH: A glance at the landscape of pharmacological treatment.
The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease.
The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease.
Co-administration of APD668, a G protein-coupled receptor 119 agonist and linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in mice fed on a high trans-fat diet.
Role of folate in nonalcoholic fatty liver disease.
A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats.